… patient-reported outcomes to predict survival across the disease trajectory for patients with …
In this study, we validated the model to also predict the risk for having low performance status …

… performance status of critically ill cancer patients 2 … patients to mortality of patients without
cancer. Further, we aimed to identify factors associated with 2-year mortality in cancer patients. …

… for patients with epidermal growth factor receptor (EGFR)-mutated non-small-cell lung
cancer (NSCLC). However, data on the use of afatinib in patients with poor performance status (…

… Performance status (PS) of a patient is the assessment of level of … for patients with advanced
malignancy. It is crucial to thoroughly assess and accurately document PS for each patient …

… Background: Patients with small cell lung cancer (SCLC) with poor performance status (PS) …
of this study was to compare survival of treated patients with PS 3-4 with untreated patients. …

… therapy and best supportive care depending on the performance status patient's (3, 4). As a
result of … of care for patients with inoperable stage III with good initial performance status (13). …

… For example, most of the older patients and patients with poor PS included in the current
study were treated with gefitinib or erlotinib. In addition, the sample size was relatively small, …

… have enrolled patients with performance status (PS) 0–1. However, around 18% of patients
with NSCLC are PS2, and the activity and safety of pembrolizumab in these patients is …

Background Quality of Life (QoL), for long, has been a multifactorial concerning issue in
oncology. The aim of this study was to determine QoL of cancer patients and its association with …

… all good performance status patients … patients with good performance status (ECOG-PS 0/1)
generally considered suitable [25]. However, the subjective nature of performance status has …